[ENetNews]
On November 17, REV-MED participated in the Korean Society of Aesthetic Surgery & Aesthetic and Future Medicine Conference, held at the Gangnam SC Convention Center, where it showcased its NovaStem product lineup.
The event featured a wide range of lectures, from the basics of aesthetic surgery to non-invasive cosmetic procedures, laser treatments, obesity management, stem cell therapies, and future medical advancements. Numerous biomedical companies also participated, exhibiting medical devices and pharmaceuticals.
REV-MED highlighted its minimally manipulated biological medical device NovaStem lineup, which utilizes autologous cells, along with its 1064nm wavelength laser for pain relief and various LED-based medical devices. The exhibition prominently featured NovaStem BC and NovaStem BMAC, two key products from its NovaStem line.
The NovaStem kits are designed to collect autologous blood and bone marrow and concentrate biological agents with minimal manipulation. The extracted cells have shown promising results in scar treatment, tissue regeneration, skin tone improvement, and even chronic urticaria and atopic dermatitis, with ongoing research expanding potential indications for these devices.
Notably, procedures that inject stem cells and immune cells concentrated from blood are increasingly combined with laser lifting treatments, skin boosters, and other traditional programs, producing significant synergistic effects. As a result, the number of clinics adopting NovaStem BC for such treatments continues to grow steadily.
A REV-MED representative stated, "As these products have applications across diverse fields, we actively participate in numerous domestic conferences and plan to continue promoting the technological superiority of our products at various conferences and events in 2025. Our ultimate goal is to solidify our position as a global leader in the K-biomedical sector."
Reporter: Han Jeong-eun (han@enetnews.co.kr)
Source: ENetNews https://www.enetnews.co.kr/news/articleView.html?idxno=31762
[ENetNews]
On November 17, REV-MED participated in the Korean Society of Aesthetic Surgery & Aesthetic and Future Medicine Conference, held at the Gangnam SC Convention Center, where it showcased its NovaStem product lineup.
The event featured a wide range of lectures, from the basics of aesthetic surgery to non-invasive cosmetic procedures, laser treatments, obesity management, stem cell therapies, and future medical advancements. Numerous biomedical companies also participated, exhibiting medical devices and pharmaceuticals.
REV-MED highlighted its minimally manipulated biological medical device NovaStem lineup, which utilizes autologous cells, along with its 1064nm wavelength laser for pain relief and various LED-based medical devices. The exhibition prominently featured NovaStem BC and NovaStem BMAC, two key products from its NovaStem line.
The NovaStem kits are designed to collect autologous blood and bone marrow and concentrate biological agents with minimal manipulation. The extracted cells have shown promising results in scar treatment, tissue regeneration, skin tone improvement, and even chronic urticaria and atopic dermatitis, with ongoing research expanding potential indications for these devices.
Notably, procedures that inject stem cells and immune cells concentrated from blood are increasingly combined with laser lifting treatments, skin boosters, and other traditional programs, producing significant synergistic effects. As a result, the number of clinics adopting NovaStem BC for such treatments continues to grow steadily.
A REV-MED representative stated, "As these products have applications across diverse fields, we actively participate in numerous domestic conferences and plan to continue promoting the technological superiority of our products at various conferences and events in 2025. Our ultimate goal is to solidify our position as a global leader in the K-biomedical sector."
Reporter: Han Jeong-eun (han@enetnews.co.kr)
Source: ENetNews https://www.enetnews.co.kr/news/articleView.html?idxno=31762